Institutional Repository UDD

Mortality in people with psychotic disorders in Finland: a population-based 13-year follow-up study

Show simple item record Keinänen, Jaakko Mantere, Outi Markkula, Niina Partti, Krista Perälä, Jonna Saarni, Samuli I. Härkänen, Tommi Suvisaari, Jaana 2017-08-28T19:36:26Z 2017-08-28T19:36:26Z 2017
dc.identifier.citation Schizophr Res. 2017 May 9. pii: S0920-9964(17)30257-8 es_CL
dc.identifier.uri es_CL
dc.description.abstract OBJECTIVES: We conducted a population based study aiming at finding predictors of mortality in psychotic disorders and evaluating the extent to which sociodemographic, lifestyle and health-related factors explain the excess mortality. METHODS: In a nationally representative sample of Finns aged 30-70years (n=5642), psychotic disorders were diagnosed using structured interviews and medical records in 2000-2001. Information on mortality and causes of death was obtained of those who died by the end of year 2013. Cox proportional hazards models were used to investigate the mortality risk. RESULTS: No people with affective psychoses (n=36) died during the follow-up, thus the analysis was restricted to non-affective psychotic disorders (NAP) (n=106). Adjusting for age and sex, NAP was statistically significantly associated with all-cause mortality (hazard ratio (HR) 2.99, 95% CI 2.03-4.41) and natural-cause mortality (HR 2.81, 95% CI 1.85-4.28). After adjusting for sociodemographic factors, health status, inflammation and smoking, the HR dropped to 2.11 (95% CI 1.10-4.05) for all-cause and to 1.98 (95% CI 0.94-4.16) for natural-cause mortality. Within the NAP group, antipsychotic use at baseline was associated with reduced HR for natural-cause mortality (HR 0.25, 95% CI 0.07-0.96), and smoking with increased HR (HR 3.54, 95% CI 1.07-11.69). CONCLUSIONS: The elevated mortality risk in people with NAP is only partly explained by socioeconomic factors, lifestyle, cardio-metabolic comorbidities and inflammation. Smoking cessation should be prioritized in treatment of psychotic disorders. More research is needed on the quality of treatment of somatic diseases in people with psychotic disorders. es_CL
dc.format.extent 1 es_CL
dc.language.iso en_US es_CL
dc.publisher Elsevier es_CL
dc.subject Comorbidity es_CL
dc.subject Mortality es_CL
dc.subject Psychotic disorders es_CL
dc.subject Somatic disease es_CL
dc.title Mortality in people with psychotic disorders in Finland: a population-based 13-year follow-up study es_CL
dc.type Artículo es_CL

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account